-

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

Improving the World of Dietary Supplements with a Breadth of Proven Brands.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutting-edge dietary supplement plant-based ingredients portfolio of innovative and trusted brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™ in hall 4 at booth 4F25, May 20-22, at the Fira Barcelona Gran Via.

"We are excited to highlight vivid examples of how our high-quality functional ingredients and technical expertise help our customers produce superior supplements," said Firat Nalbantoglu, EMEA commercial leader, IFF Pharma Solutions. "Our technical and commercial experts look forward to offering solutions for formulation and processing challenges. If you aim to enhance efficacy and bioavailability in your dietary supplements, we invite you to discover new possibilities with us."

IFF Pharma Solutions is committed to advancing the dietary supplement industry with its portfolio of high-performance ingredients, offering plant-based solutions and vegan alternatives, as well as reliable technologies for immediate and controlled release:

  • SeaGel® and VERDIGEL™ SC: These plant-based alternatives to gelatin offer clean-label, non-GMO solutions for superior quality and high performance vegan softgels.
  • GRINDSTED® Pectin Premium: A renowned, citrus-sourced ingredient for plant-based gummies that delivers an excellent consumer experience.
  • Avicel®: A cellulose-based tablet binder and filler, Avicel® ensures the production of small, high-quality tablets with low-dusting and efficient tableting processes. Avicel® acts as a suspending agent, enhancing the stability and efficacy of liquid formulations.
  • Ac-Di-Sol®: A non-GMO cellulose-based tablet disintegrant that delivers nutritional ingredients faster.
  • METHOCEL™: A versatile cellulose-based solution for vegetarian hard capsules and controlled-release tablet matrices – resistant to heat and humidity conditions.
  • Accelerate®: A cellulose-based super disintegrant for immediate release.

Visit here to learn more about IFF Pharma Solutions.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

Industry:

International Flavors & Fragrances

NYSE:IFF
Release Versions
English

Contacts

Britta Meys
Global Communications Lead EMEA
+49 151 14486359
britta.meys@iff.com

More News From International Flavors & Fragrances

IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due...

IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Po...

IFF Completes Divestiture of Nitrocellulose Business

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF’s Pharma Solutions business unit. “The divestiture of our nitrocellulose business builds upon our deleveraging journey an...
Back to Newsroom